Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izuma Nakayama

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Japanese Journal of Clinical Oncology|May 22, 2025
Therapeutic strategy for scirrhous type gastric cancerIzuma Nakayama
Chinese Clinical Oncology|November 10, 2025
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial's insights and future perspectivesIzuma Nakayama
International Journal of Clinical Oncology|July 27, 2023
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectivesDaisuke Takahari, Izuma Nakayama
Expert Opinion on Biological Therapy|August 22, 2024
The current status of immunotherapy and future horizon in the treatment of metastatic and locally advanced gastroesophageal adenocarcinomaIzuma Nakayama, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 22, 2025
Cell-Based Therapies in GI Cancers: Current Landscape and Future DirectionsIzuma Nakayama, Kohei Shitara
Journal of Clinical Medicine|May 13, 2023
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative ReviewIzuma Nakayama, Daisuke Takahari
Expert Review of Clinical Pharmacology|August 25, 2025
Pharmacotherapy for previously treated gastric cancer patients: current options and future developmentsSeiya Sato, Izuma Nakayama, Kohei Shitara
Future Oncology (London, England)|November 19, 2025
Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive reviewAmane Jubashi, Izuma Nakayama, Kohei Shitara
Gastroenterology Report|March 11, 2026
Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN eraDai Okemoto, Izuma Nakayama, Kohei Shitara
Therapeutic Advances in Medical Oncology|June 19, 2025
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyondKazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Japanese Journal of Clinical Oncology|May 22, 2025
Therapeutic strategy for scirrhous type gastric cancerIzuma Nakayama
Chinese Clinical Oncology|November 10, 2025
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial's insights and future perspectivesIzuma Nakayama
International Journal of Clinical Oncology|July 27, 2023
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectivesDaisuke Takahari, Izuma Nakayama
Expert Opinion on Biological Therapy|August 22, 2024
The current status of immunotherapy and future horizon in the treatment of metastatic and locally advanced gastroesophageal adenocarcinomaIzuma Nakayama, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 22, 2025
Cell-Based Therapies in GI Cancers: Current Landscape and Future DirectionsIzuma Nakayama, Kohei Shitara
Journal of Clinical Medicine|May 13, 2023
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative ReviewIzuma Nakayama, Daisuke Takahari
Expert Review of Clinical Pharmacology|August 25, 2025
Pharmacotherapy for previously treated gastric cancer patients: current options and future developmentsSeiya Sato, Izuma Nakayama, Kohei Shitara
Future Oncology (London, England)|November 19, 2025
Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive reviewAmane Jubashi, Izuma Nakayama, Kohei Shitara
Gastroenterology Report|March 11, 2026
Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN eraDai Okemoto, Izuma Nakayama, Kohei Shitara
Therapeutic Advances in Medical Oncology|June 19, 2025
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyondKazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Pageof 10